The reagents are validated on the TA series of platelet aggregometer and are designed to be easy to use and provide class-leading performance to aid the diagnosis of inherited platelet disorders (Glanzmann's thrombasthenia, Bernard-Soulier syndrome, storage pool disease...) or acquired platelet disorders.
Agonists available at launch will include ADP, Arachidonic Acid, Collagen, Epinephrine and TRAP-6. They come in convenient pack sizes and have excellent stability to minimise waste and produce simple workflows with minimal dilution steps.
Screening for platelets disorders by studying platelet response to the different agonists activating various membrane receptors and signalling pathways: